Breaking News

Glaxo to Pay $488.7 Million Fine to End China Corruption Probe
Tweet TWEET

AERL: Baring Invest Serv: Form 8.3 - AER Lingus Group Plc

  AERL: Baring Invest Serv: Form 8.3 - AER Lingus Group Plc

UK Regulatory Announcement

LONDON

    FORM 8.3

    

    IRISH TAKEOVER PANEL

    

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
  RULES, 2007 (AS AMENDED)

    

    DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
    OR MORE

    

    1. KEY INFORMATION
   Name of person dealing (Note 1)        Baring Asset Management
   Company dealt in                        AER Lingus Group Plc
    Class of relevant security to which     AER Lingus Group Plc Ordinary
   the dealings being disclosed relate     Shares
    (Note 2)
   Date of dealing                         18^th January 2013
    

    2. INTERESTS AND SHORT POSITIONS

    

    (a) Interests and short positions (following dealing) in the class of
    relevant security dealt in (Note 3)
                                          Long                 Short
                                          Number (%)            Number (%)
   (1) Relevant securities                 8,272,305 1.549%      
   (2) Derivatives (other than options)                         
   (3) Options and agreements to                                
    purchase/sell
   Total                                   8,272,305 1.549%      N/A
   (b) Interests and short positions in relevant securities of the company,
    other than the class dealt in (Note 3)
   Class of relevant security:             Long                  Short
                                          Number (%)            Number (%)
   (1) Relevant securities                                      
   (2) Derivatives (other than options)                         
   (3) Options and agreements to                                
    purchase/sell
   Total                                   N/A                   N/A
   

    3. DEALINGS (Note 4)

  

    (a) Purchases and sales
   Purchase/sale      Number of relevant securities     Price per unit (Note 5)
   Purchase            3,641 Ordinary shares              €1.2205
    

    (b) Derivatives transactions (other than options transactions)
                   Nature of        Number of relevant securities    Price per unit
    Product        transaction
   name, e.g.                                                   
    CFD            
                                    (Note 7)                         (Note 5)
                   (Note 6)
   N/A                                                            
    

    (c) Options transactions in respect of existing relevant securities

    

    (i) Writing, selling, purchasing or varying
    Product   Writing,      Number of               Type,
    name,     selling,      securities              e.g.                 Option money
   e.g.     purchasing,  to which    Exercise  American,  Expiry  paid/received
    call      varying       the option   price      European    date     per unit
    option    etc.          relates                 etc.                 (Note 5)
                            (Note 7)
   N/A                                                             
    

   

    (ii) Exercising
   Product name,       Number of securities               Exercise price per unit
    e.g. call option                                       (Note 5)
   N/A                                                   
    

   

    (d) Other dealings (including transactions in respect of new securities) (Note 4)
    Nature of                                              Price per unit
   transaction         Details
                                                           (if applicable) (Note 5)
    (Note 8)
   N/A                                                   
   

  4. OTHER INFORMATION

 

  Agreements, arrangements or understandings relating to options or
  derivatives
  Full details of any agreement, arrangement or understanding between the
  person disclosing and any other person relating to the voting rights of any
 relevant securities under any option referred to on this form or relating
  to the voting rights or future acquisition or disposal of any relevant
  securities to which any derivative referred to on this form is referenced.
  If none, this should be stated.
 N/A
  

 

  Is a Supplemental Form 8 attached? (Note 9) NO
 Date of disclosure                                21^st January 2013
 Contact name                                       Kerrie Barnett
 Telephone number                                   +44 207 214 1404
 If a connected EFM, name of                        
  offeree/offeror with which connected
 If a connected EFM, state nature of                
  connection (Note 10)
  

  

Contact:

Baring Invest Serv
 
Press spacebar to pause and continue. Press esc to stop.